tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market

Rohto Pharmaceutical Co (RPHCF) Income Statement

Compare
3 Followers

Rohto Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Rohto Pharmaceutical Co's total revenue was ¥82.73B, an increase of 0.93% from the same quarter last year. In Q4, Rohto Pharmaceutical Co's net income was ¥6.20B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 308.63B¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B
Gross Profit
¥ 169.46B¥ 154.93B¥ 135.13B¥ 114.10B¥ 104.96B
Operating Expenses
¥ 131.00B¥ 114.77B¥ 101.59B¥ 86.24B¥ 83.09B
Depreciation and Amortization
¥ 13.14B¥ 8.69B¥ 7.80B¥ 7.69B¥ 6.75B
EBITDA
¥ 51.61B¥ 48.85B¥ 41.34B¥ 35.55B¥ 28.61B
Operating Income
¥ 38.47B¥ 40.17B¥ 33.54B¥ 27.86B¥ 21.87B
Other Income/Expenses
¥ 3.87B¥ 1.35B¥ 752.00M¥ 16.00M¥ 1.14B
Pretax Income
¥ 42.33B¥ 41.52B¥ 34.29B¥ 27.87B¥ 23.01B
Net Income
¥ 31.00B¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B
Per Share Metrics
Basic EPS
¥ 136.11¥ 135.60¥ 115.62¥ 92.61¥ 73.39
Diluted EPS
¥ 135.44¥ 135.21¥ 115.29¥ 92.34¥ 73.18
Weighted Average Shares Outstanding
227.80M 228.14M 228.14M 228.14M 228.14M
Weighted Average Shares Outstanding (Diluted)
228.90M 228.80M 228.80M 228.80M 228.80M
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History